GSK Looks For New Chair To Lead It Through New Strategic Direction
Executive Summary
GSK’s non-exec chairman steps down from the UK firm, just a month after announcing a split that will reshape the company.
| Table |
|---|
Advertisement
Related Content
Pfizer Consumer Combo Deal Frees Capital For GSK Pharma Investment
New CFO Mackay Completes Top Table At GSK
Topics
- Subjects
- Companies
- Leadership
- Strategy
- Commercial
- Industries
- BioPharmaceutical
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
SC124518
Ask The Analyst
Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
SC124518
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.